Insider · CIK 0002014361
Mark Hancock
Files at PACS (PACS Group, Inc.). First filing Jun 17, 2026, latest Sep 15, 2026.
In brief
Mark Hancock files SEC Form 4 as director, 10% owner, CFO and chair at PACS (PACS Group, Inc.). Since Jun 17, 2026, Mark Hancock has reported 0 open-market buys worth $0 and 7 open-market sells worth $41M, the latest filed on Sep 15, 2026.
A track record needs three past buys with six months of prices behind them; Mark Hancock has 0, so none is measured yet.
The newest scored trade: sold $13M of PACS on Sep 14, 2026, filed Sep 15, 2026, scored 35 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 7 sells worth $41M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PACS: PACS Group, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 35Weak | PACS Group, Inc. | $13M 300,000 shares | -1% | - | |
| 30Weak | PACS Group, Inc. | $614k 13,628 shares | -0% | +483% from low-0% from high | |
| 35Weak | PACS Group, Inc. | $1.1M 25,304 shares | -0% | +471% from low-2% from high | |
| 35Weak | PACS Group, Inc. | $7.3M 161,068 shares | -0% | +475% from low0% from high | |
| 33Weak | PACS Group, Inc. | $8.1M 200,000 shares | -0% | +428% from low-3% from high | |
| 33Weak | PACS Group, Inc. | $2.2M 63,680 shares | -0% | +357% from low-16% from high | |
| 33Weak | PACS Group, Inc. | $8.6M 236,320 shares | -0% | +370% from low-14% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Sep 15, 2026 | PACS PACS Group, Inc. | 144,318 0.09% of outstanding | $6.4M | Sep 14, 2026 | $28M |
| Sep 15, 2026 | PACS PACS Group, Inc. | 155,682 0.10% of outstanding | $6.6M | Sep 15, 2026 | $34M |
| Jul 15, 2026 | PACS PACS Group, Inc. | 3,332 0.02% of outstanding | $150k | Jul 15, 2026 | $28M |
| Jul 14, 2026 | PACS PACS Group, Inc. | 10,296 0.07% of outstanding | $464k | Jul 14, 2026 | $27M |
| Jul 9, 2026 | PACS PACS Group, Inc. | 4,966 0.03% of outstanding | $224k | Jul 9, 2026 | $27M |
| Jul 8, 2026 | PACS PACS Group, Inc. | 20,338 0.13% of outstanding | $917k | Jul 8, 2026 | $26M |
| Jul 6, 2026 | PACS PACS Group, Inc. | 142,163 0.90% of outstanding | $6.4M | Jul 6, 2026 | $20M |
| Jul 2, 2026 | PACS PACS Group, Inc. | 12,825 0.08% of outstanding | $577k | Jul 2, 2026 | $19M |
| Jul 1, 2026 | PACS PACS Group, Inc. | 6,080 0.04% of outstanding | $274k | Jul 1, 2026 | $19M |
| Jun 26, 2026 | PACS PACS Group, Inc. | 61,931 0.39% of outstanding | $2.5M | Jun 26, 2026 | $16M |
| Jun 25, 2026 | PACS PACS Group, Inc. | 138,069 0.87% of outstanding | $5.6M | Jun 25, 2026 | $11M |
| Jun 17, 2026 | PACS PACS Group, Inc. | 63,680 0.40% of outstanding | $2.2M | Jun 17, 2026 | $8.6M |
| Jun 16, 2026 | PACS Pacs Group, Inc. | 153,254 0.10% of outstanding | $5.6M | Jun 15, 2026 | none |
| Jun 16, 2026 | PACS PACS Group, Inc. | 83,066 0.52% of outstanding | $3.0M | Jun 16, 2026 | $5.6M |
Transactions
Every row this insider has filed, 28 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | PACS PACS Group, Inc. | SOpen-market sale Common Stock10b5-1 | -137,684 | $44.56 | $6.1M | 53,681,200 | 29 d ago |
| Sep 14, 2026 | PACS PACS Group, Inc. | SOpen-market sale Common Stock10b5-1 | -6,634 | $44.91 | $298k | 53,674,566 | 29 d ago |
| Sep 15, 2026 | PACS PACS Group, Inc. | SOpen-market sale Common Stock10b5-1 | -104,132 | $42.09 | $4.4M | 53,570,434 | 29 d ago |
| Sep 15, 2026 | PACS PACS Group, Inc. | SOpen-market sale Common Stock10b5-1 | -30,466 | $42.89 | $1.3M | 53,539,968 | 29 d ago |
| Sep 15, 2026 | PACS PACS Group, Inc. | SOpen-market sale Common Stock10b5-1 | -21,084 | $43.75 | $922k | 53,518,884 | 29 d ago |
| Aug 18, 2026 | PACS PACS Group, Inc. | GGift Common Stock | -88,000 | $0.00 | $0 | 53,818,884 | Aug 27, 2026 |
| Jul 14, 2026 | PACS PACS Group, Inc. | SOpen-market sale Common Stock10b5-1 | -10,296 | $45.04 | $464k | 53,910,216 | Jul 16, 2026 |
| Jul 15, 2026 | PACS PACS Group, Inc. | SOpen-market sale Common Stock10b5-1 | -3,332 | $45.05 | $150k | 53,906,884 | Jul 16, 2026 |
| Jul 8, 2026 | PACS PACS Group, Inc. | SOpen-market sale Common Stock10b5-1 | -20,338 | $45.07 | $917k | 53,925,478 | Jul 10, 2026 |
| Jul 9, 2026 | PACS PACS Group, Inc. | SOpen-market sale Common Stock10b5-1 | -4,966 | $45.06 | $224k | 53,920,512 | Jul 10, 2026 |
| Jul 1, 2026 | PACS PACS Group, Inc. | AGrant or award Common Stock10b5-1 | +4,287 | $0.00 | $0 | 54,106,884 | Jul 6, 2026 |
| Jul 1, 2026 | PACS PACS Group, Inc. | SOpen-market sale Common Stock10b5-1 | -6,080 | $45.02 | $274k | 54,100,804 | Jul 6, 2026 |
| Jul 2, 2026 | PACS PACS Group, Inc. | SOpen-market sale Common Stock10b5-1 | -12,825 | $45.01 | $577k | 54,087,979 | Jul 6, 2026 |
| Jul 6, 2026 | PACS PACS Group, Inc. | SOpen-market sale Common Stock10b5-1 | -142,163 | $45.33 | $6.4M | 53,945,816 | Jul 6, 2026 |
| Jun 25, 2026 | PACS PACS Group, Inc. | SOpen-market sale Common Stock10b5-1 | -138,069 | $40.33 | $5.6M | 54,164,528 | Jun 26, 2026 |
| Jun 26, 2026 | PACS PACS Group, Inc. | SOpen-market sale Common Stock10b5-1 | -61,731 | $40.50 | $2.5M | 54,102,797 | Jun 26, 2026 |
| Jun 26, 2026 | PACS PACS Group, Inc. | SOpen-market sale Common Stock10b5-1 | -200 | $41.01 | $8,202 | 54,102,597 | Jun 26, 2026 |
| Jun 17, 2026 | PACS PACS Group, Inc. | SOpen-market sale Common Stock10b5-1 | -60,364 | $35.28 | $2.1M | 54,305,913 | Jun 22, 2026 |
| Jun 17, 2026 | PACS PACS Group, Inc. | SOpen-market sale Common Stock10b5-1 | -3,316 | $35.75 | $119k | 54,302,597 | Jun 22, 2026 |
| Jun 15, 2026 | PACS PACS Group, Inc. | SOpen-market sale Common Stock10b5-1 | -134,093 | $36.23 | $4.9M | 54,468,504 | Jun 17, 2026 |
| Jun 15, 2026 | PACS PACS Group, Inc. | SOpen-market sale Common Stock10b5-1 | -19,138 | $37.05 | $709k | 54,449,366 | Jun 17, 2026 |
| Jun 15, 2026 | PACS PACS Group, Inc. | SOpen-market sale Common Stock10b5-1 | -23 | $37.88 | $871 | 54,449,343 | Jun 17, 2026 |
| Jun 16, 2026 | PACS PACS Group, Inc. | SOpen-market sale Common Stock10b5-1 | -83,066 | $35.90 | $3.0M | 54,366,277 | Jun 17, 2026 |
| Mar 24, 2026 | PACS PACS Group, Inc. | AGrant or award Common Stock | +98,154 | $0.00 | $0 | 54,602,597 | Mar 26, 2026 |
| Mar 5, 2026 | PACS PACS Group, Inc. | GGift Common Stock | -300,000 | $0.00 | $0 | 54,504,443 | Mar 9, 2026 |
| Jan 15, 2026 | PACS PACS Group, Inc. | FTax withholding Common Stock | -12,774 | $39.49 | $504k | 54,804,443 | Jan 20, 2026 |
| Dec 17, 2025 | PACS PACS Group, Inc. | AGrant or award Common Stock | +150,000 | $0.00 | $0 | 54,776,199 | Dec 19, 2025 |
| Dec 17, 2025 | PACS PACS Group, Inc. | AGrant or award Common Stock | +41,018 | $0.00 | $0 | 54,817,217 | Dec 19, 2025 |
Questions about Mark Hancock
Answered from the filings on this page, as of the latest one.
Is Mark Hancock buying or selling?
In the last 12 months Mark Hancock reported 0 open-market buys worth $0 and 7 open-market sells worth $41M on SEC Form 4; the latest was sold $13M of PACS on Sep 14, 2026. Grants, option exercises and tax withholding are not counted.
How did Mark Hancock's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Mark Hancock has 0.
Where does Mark Hancock file Form 4?
Mark Hancock has filed Form 4 at PACS (PACS Group, Inc.) as Co Fndr; Exec V Chair. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.